Omega-3 Fish Oil: EPA, DHA, Forms, and Label Guide

Fish oil supplies long-chain omega-3 fatty acids, primarily eicosapentaenoic acid, or EPA, and docosahexaenoic acid, or DHA. EPA and DHA are incorporated into cell membranes and participate in lipid signaling. DHA is especially concentrated in the retina and brain, but a biological role does not guarantee that a fish oil supplement improves cognition, mood, joints, or cardiovascular outcomes. ¹

Alpha-linolenic acid, or ALA, is a different omega-3 found in foods such as flaxseed, chia, walnuts, and some plant oils. The body can convert ALA to EPA and DHA, but conversion is limited. A label that lists 1,000 mg ALA should not be read as 1,000 mg EPA plus DHA. ¹

Consider a two-softgel serving that lists 2,000 mg fish oil, 360 mg EPA, and 240 mg DHA. The disclosed EPA plus DHA total is 600 mg per two softgels. That is 300 mg per softgel. The remaining oil mass is not automatically additional EPA or DHA.

If the directions suggest more than one serving per day, keep the amount per listed serving and the proposed daily amount as separate calculations. Also check multivitamins, prenatal products, cod liver oil, krill oil, and other omega-3 products before assuming one bottle represents the complete stack.

NIH notes that natural triglycerides, re-esterified triglycerides, and free fatty acids have somewhat higher bioavailability than ethyl esters, while all forms can increase plasma EPA and DHA. Short pharmacokinetic studies also show that formulation can change short-term exposure. These findings do not support a universal “70% better” rule or prove that one retail product has a better health outcome. ^{1 2}

EPA and DHA supplements can lower triglyceride levels, but treatment of high triglycerides uses indication-specific doses and often prescription products under clinical supervision. This does not turn an ordinary fish oil supplement into a treatment for cardiovascular disease. ¹

Cardiovascular outcome trials have not produced one uniform result. In VITAL, 1 g per day of marine omega-3 did not significantly reduce the primary composite of major cardiovascular events in a generally healthy primary-prevention population. REDUCE-IT found benefit from 4 g per day of prescription icosapent ethyl in selected statin-treated patients with elevated triglycerides. STRENGTH used a different prescription EPA plus DHA preparation at 4 g per day, found no benefit for its primary cardiovascular outcome, and reported more atrial fibrillation. ^{3 4 5}

These trials studied different populations, preparations, doses, comparators, and outcomes. A retail fish oil label cannot inherit a prescription result because it contains some EPA, and an ethyl ester label should not be called ineffective when a specific ethyl ester prescription product has direct outcome evidence.

Fish oil 1,000 mg; EPA 180 mg; DHA 120 mg

The serving discloses 300 mg combined EPA plus DHA. The other 700 mg of oil should not be relabeled as active EPA or DHA.

Fish oil concentrate 1,000 mg; EPA 500 mg; DHA 250 mg

The serving discloses 750 mg combined EPA plus DHA. Compare the serving size and form before treating this as equivalent to the first label.

Total omega-3 fatty acids 1,000 mg

This gives an aggregate but no EPA and DHA breakdown. The label is less useful for matching evidence or comparing the two main fatty acids.

Omega-3 marine blend 1,000 mg; fish oil, krill oil, EPA, and DHA

If individual amounts are hidden, 1,000 mg belongs to the full blend. It cannot be assigned to fish oil, krill oil, EPA, or DHA separately.

The U.S. Institute of Medicine did not establish a formal upper limit for omega-3 fatty acids. NIH reports that FDA and EFSA safety assessments found supplemental EPA plus DHA intakes up to about 5 g per day safe when used as recommended. This is a safety context, not a target, a treatment dose, or a guarantee of suitability. ¹

Higher-dose omega-3 interventions have produced a small atrial fibrillation signal in some large cardiovascular trials. Fish oil can also have antiplatelet effects, although clinically important bleeding has not been consistently shown at ordinary intakes. People using warfarin or similar anticoagulants should discuss the complete EPA and DHA intake with the treating clinician and follow monitoring or procedure-specific instructions. ^{1 4 5}

Common adverse effects are usually gastrointestinal, including unpleasant taste, reflux, nausea, discomfort, or diarrhea. Fish allergy, pregnancy or breastfeeding, a history of atrial fibrillation, upcoming surgery, regular medication use, or clinician-directed triglyceride treatment needs individualized review. Cod liver oil also requires separate vitamin A and vitamin D accounting.